Transplantation of allogeneic cryopreserved hematopoietic cell grafts during the Covid‐19 pandemic: A National Marrow Donor Program perspective

Podobne zapisy

• The Effect of Donor Graft Cryopreservation on Allogeneic Hematopoietic Cell Transplant Outcomes: A CIBMTR Analysis. Implications During The COVID-19 Pandemic
  od: Hsu, Jack W., i wsp.
  Wydane: (2021)
• Urgent Time to Allogeneic Hematopoietic Cell Transplantation: A National Survey of Transplant Physicians and Unrelated Donor Search Coordinators Facilitated by the Histocompatibility Advisory Group to the National Marrow Donor Program
  od: Pidala, Joseph, i wsp.
  Wydane: (2019)
• Graft Cryopreservation Does Not Impact Overall Survival after Allogeneic Hematopoietic Cell Transplantation Using Post-Transplantation Cyclophosphamide for Graft-versus-Host Disease Prophylaxis
  od: Hamadani, Mehdi, i wsp.
  Wydane: (2020)
• Hematopoietic Cell Transplantation with Cryopreserved Grafts for Severe Aplastic Anemia
  od: Eapen, Mary, i wsp.
  Wydane: (2020)
• Cryopreservation of Unrelated Hematopoietic Stem Cells from a Blood and Marrow Donor Bank During the COVID-19 Pandemic: A Nationwide Survey by the Japan Marrow Donor Program
  od: Kanda, Yoshinobu, i wsp.
  Wydane: (2021)